Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.

about

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma.

P2860

Q55714688-4A331FDA-39A5-4C6F-A13D-22CF44B1E119

P2860

Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.

Item

http://www.wikidata.org/entity/Q38610976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prognostic factors for disease ...... s with uterine carcinosarcoma.

@en

type

Item

label

Prognostic factors for disease ...... s with uterine carcinosarcoma.

@en

prefLabel

Prognostic factors for disease ...... s with uterine carcinosarcoma.

@en

P1476

Prognostic factors for disease ...... ts with uterine carcinosarcoma

@en

P2093

Bulut Varlı

http://www.w3.org/2001/XMLSchema#string

Mete Güngör

http://www.w3.org/2001/XMLSchema#string

Salih Taşkın

http://www.w3.org/2001/XMLSchema#string

P2860

Uterine carcinosarcoma: A review of the literature.

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.

Clinical features and outcomes of uterine and ovarian carcinosarcoma.

Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.

Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study.

The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.

Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.

P2888

s10147-017-1181-3

P304

114-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-017-1181-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Can Ates

Firat Ortac

Yavuz Emre Şükür

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28836024

http://www.w3.org/2001/XMLSchema#string

Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.

about

P2860

P2860

Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698